Clinical trials data
Symbol Coding in pain and fatigue trials: 82 registered studies
Every registered pain and fatigue study on ClinicalTrials.gov that names Symbol Coding in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered pain and fatigue studies name it in an outcome measure
- 82
- Name it in a primary outcome, 21%
- 17 of 82
Tests named in the same studies
- 1
Verbal Learning22 studies, 2 as a primary outcome
- 2
Trail Making Test13 studies, 4 as a primary outcome
- 3
Stroop Color-Word Test10 studies, 3 as a primary outcome
- 4
Digit Span Test10 studies, 2 as a primary outcome
- 5
Verbal Fluency10 studies, 2 as a primary outcome
- 6
Paced Visual Serial Addition Test9 studies, 4 as a primary outcome
- 7
N-Back Task5 studies, 1 as a primary outcome
- 8
Selective Reminding Task5 studies, 1 as a primary outcome
- 9
Psychomotor Vigilance Task4 studies, 1 as a primary outcome
- 10
Category Fluency3 studies, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 1 | 0 |
| 2010 | 2 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 6 | 0 |
| 2014 | 2 | 0 |
| 2015 | 4 | 2 |
| 2016 | 3 | 1 |
| 2017 | 2 | 0 |
| 2018 | 2 | 2 |
| 2019 | 1 | 0 |
| 2020 | 5 | 2 |
| 2021 | 4 | 2 |
| 2022 | 4 | 0 |
| 2023 | 10 | 0 |
| 2024 | 9 | 4 |
| 2025 | 6 | 0 |
| 2026 | 12 | 1 |
Phases and study sizes
By phase
- Phase 12 studies, 0 as a primary outcome
- Phase 1/22 studies, 0 as a primary outcome
- Phase 217 studies, 4 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 38 studies, 1 as a primary outcome
- Phase 43 studies, 1 as a primary outcome
- Not applicable36 studies, 7 as a primary outcome
- Observational13 studies, 4 as a primary outcome
Participants per study
- Phase 2104 median, 38 to 131
- Not applicable50 median, 34 to 98
- Observational89 median, 58 to 126
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 17 | 104 | 38 to 131 |
| Not applicable | 35 | 50 | 34 to 98 |
| Observational | 12 | 89 | 58 to 126 |
When pain and fatigue trials measure it
Latest time point of each outcome
- Within a day13 outcomes, 2 as a primary outcome
- Up to 4 weeks18 outcomes, 2 as a primary outcome
- 1 to 3 months24 outcomes, 5 as a primary outcome
- 3 to 6 months12 outcomes, 3 as a primary outcome
- 6 to 12 months7 outcomes, 1 as a primary outcome
- 1 to 2 years1 outcomes, 1 as a primary outcome
- Over 2 years1 outcomes, 1 as a primary outcome
- No duration given6 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
76 of the 82 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting17 studies, 2 as a primary outcome
- Not yet recruiting8 studies, 1 as a primary outcome
- Active, not recruiting3 studies, 1 as a primary outcome
- Completed42 studies, 12 as a primary outcome
- Stopped early4 studies, 0 as a primary outcome
- Status unknown8 studies, 1 as a primary outcome
What they test
- Behavioral14 studies, 1 as a primary outcome
- Drug33 studies, 6 as a primary outcome
- Device15 studies, 2 as a primary outcome
- Dietary supplement2 studies, 1 as a primary outcome
- Diagnostic test3 studies, 1 as a primary outcome
- Other18 studies, 3 as a primary outcome
- None given8 studies, 3 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States27 studies, 3 as a primary outcome
- Türkiye7 studies, 2 as a primary outcome
- Denmark6 studies, 3 as a primary outcome
- Spain6 studies, 2 as a primary outcome
- Germany5 studies, 1 as a primary outcome
- Switzerland5 studies, 0 as a primary outcome
- France4 studies, 1 as a primary outcome
- United Kingdom4 studies, 0 as a primary outcome
- Canada3 studies, 1 as a primary outcome
- Czechia3 studies, 1 as a primary outcome
- Italy3 studies, 1 as a primary outcome
- Norway3 studies, 0 as a primary outcome
28 countries in all. A study with sites in several counts in each; 6 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed pain and fatigue studies that name Symbol Coding: 23 of 42, 55%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed pain and fatigue studies that name Symbol Coding | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 9, 21% | 776, 10% |
| Results on ClinicalTrials.gov only | 8, 19% | 1,139, 14% |
| A results paper only | 6, 14% | 1,711, 22% |
| Neither | 19, 45% | 4,327, 54% |
The 82 studies
82 studies match. 17 name Symbol Coding in a primary outcome. Median size 72 participants. Median time to the primary outcome: 9 weeks.
Loading 82 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 1 | 0 |
| 2010 | 2 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 6 | 0 |
| 2014 | 2 | 0 |
| 2015 | 4 | 2 |
| 2016 | 3 | 1 |
| 2017 | 2 | 0 |
| 2018 | 2 | 2 |
| 2019 | 1 | 0 |
| 2020 | 5 | 2 |
| 2021 | 4 | 2 |
| 2022 | 4 | 0 |
| 2023 | 10 | 0 |
| 2024 | 9 | 4 |
| 2025 | 6 | 0 |
| 2026 | 12 | 1 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 11, other 71. Interventional 69, observational 13.
As a primary outcomeSecondary or other outcomeSymbol Coding
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07898722 | Start2025 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants40 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07852156 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants42 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07842302 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants80 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07786987 | Start2026 | PhaseObservational | ConditionsMultiple sclerosis, Pain and fatigue | Participants50 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07783074 | Start2026 | PhaseObservational | ConditionsMultiple sclerosis, Healthy volunteers, COVID-19 and long COVID, Pain and fatigue | Participants122 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07766213 | Start2026 | PhaseObservational | ConditionsMultiple sclerosis, Pain and fatigue | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07724834 | Start2026 | PhasePhase 2 | ConditionsCOVID-19 and long COVID, Pain and fatigue | Participants38 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07680738 | Start2023 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants38 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07666958 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants45 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07565688 | Start2027 | PhaseNot applicable | ConditionsPain and fatigue | Participants45 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07555379 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis, Sleep and sleep disorders, Pain and fatigue | Participants40 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07504120 | Start2025 | PhaseNot applicable | ConditionsMultiple sclerosis, Depression and bipolar disorder, Aging, frailty and exercise, Pain and fatigue | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07426991 | Start2024 | PhaseObservational | ConditionsMultiple sclerosis, Sleep and sleep disorders, Pain and fatigue | Participants837 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07409753 | Start2025 | PhasePhase 2 | ConditionsPain and fatigue | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07393672 | Start2026 | PhasePhase 2 | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants104 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07310862 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants30 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07304843 | Start2023 | PhasePhase 1/2 | ConditionsPain and fatigue | Participants207 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT07273604 | Start2015 | PhaseNot applicable | ConditionsMultiple sclerosis, Depression and bipolar disorder, Anxiety, PTSD and OCD, Pain and fatigue | Participants148 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07168447 | Start2025 | PhaseObservational | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD, Pain and fatigue | Participants85 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06956183 | Start2025 | PhaseNot applicable | ConditionsStroke, Pain and fatigue | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06831916 | Start2025 | PhasePhase 2 | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants104 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06721416 | Start2024 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants12 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06569550 | Start2024 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06386133 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants208 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06368492 | Start2024 | PhaseNot applicable | ConditionsPain and fatigue | Participants35 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many pain and fatigue trials use Symbol Coding?
82 registered pain and fatigue studies on ClinicalTrials.gov name it in an outcome measure, 17 of them in a primary outcome: 12% of the condition's 681 studies with a cognitive outcome, against 9% of all of them. It is the 3rd most named test in pain and fatigue trials.
Which tests do pain and fatigue trials use with Symbol Coding?
Verbal Learning (22 studies), the Trail Making Test (13 studies) and the Stroop Color-Word Test (10 studies).
How many participants do phase 2 pain and fatigue trials that use Symbol Coding enroll?
Half of the phase 2 studies that name it enroll 104 participants or fewer, and the middle half enroll 38 to 131. 17 of them give a size.
When do pain and fatigue trials measure Symbol Coding?
Half of the primary outcomes that name Symbol Coding are measured within 9 weeks of the start, and the middle half from 5 weeks to 6 months. 15 primary outcomes give a duration.
How many completed pain and fatigue trials that use Symbol Coding have reported results?
23 of the 42 completed studies that name it, 55%, have reported results: 17 posted them on ClinicalTrials.gov, 15 have a results paper linked to the registry record, and 9 did both. The other 19 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Symbol Key Game and Symbol Coding as one test family, so this page counts their studies together.
Run Symbol Coding in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.